China Resources Pharmaceutical Group Ltd. (HK:3320) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
China Resources Sanjiu Medical & Pharmaceutical Co., a subsidiary of China Resources Pharmaceutical Group Ltd., reported a significant rise in net profit to RMB 3.24 billion for the nine months ending September 30, 2024, up from RMB 2.69 billion the previous year. Despite this profit boost, the company experienced a decrease in cash and cash equivalents, ending the period with RMB 5.39 billion. Investors are advised to exercise caution as these unaudited financial results may be subject to adjustments.
For further insights into HK:3320 stock, check out TipRanks’ Stock Analysis page.
